Riggio Egidio, Ardoino Ilaria, Richardson Caroline E, Biganzoli Elia
Unit of Plastic and Reconstructive Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
G.A. Maccacaro Unit of Medical Statistics, Biometry and Bioinformatics, Department of Clinical Science and Community Health, University of Milan, Milan, Italy.
Eur J Plast Surg. 2017;40(3):203-212. doi: 10.1007/s00238-016-1261-z. Epub 2017 Jan 3.
Preoperative implant planning for breast reconstruction is often at risk of being changed perioperatively. This study examined which factors are associated with a change of implant selection.
Women who had unilateral two-stage breast reconstruction between 2002 and 2007 were studied. Inclusion criteria were photographic evidence of preoperative skin markings indicating breast dimensions and a selected implant model. Multivariable logistic regression was used to identify variables associated with a changed selection.
Among the 496 women studied, 308 preoperative implant choices (62.1%) were changed during surgery. A change in plan was significantly associated with symmetrization surgery involving contralateral reduction mammaplasty (OR = 1.92; 95% CI, 1.12 to 3.29) and contralateral mastopexy (OR = 2.26; 95% CI, 1.29 to 3.96), but not with BMI. The required implant width changed more than 0.5 cm in 70 cases (14.1%) while height changed more than 0.5 cm in 215 cases (43.2%). The likelihood of a change was high for large preoperative widths (OR = 9.66 for 15.5 cm) and small preoperative heights (OR = 2.97 for 10.5 cm). At a mean follow-up of 16.6 months, patient satisfaction was good or average in 92.1% of cases and 5.9% of implants had been replaced with another model, indicating that the perioperative implant selection was usually appropriate.
This study documents the frequency with which implant choices, despite accurate preoperative planning, are changed perioperatively as a result of relatively small differences in anthropomorphic measurements. Perioperative recalculation of breast dimensions may have an advantage in terms of patient reoperation rates. Changes in width were less frequent than changes in height and projection. Contralateral surgery, large width, and small height were the most influential factors. Level of Evidence: Level IV, risk / prognostic study.
乳房重建的术前植入物规划在围手术期常常有被更改的风险。本研究探讨了哪些因素与植入物选择的改变相关。
对2002年至2007年间接受单侧两阶段乳房重建的女性进行研究。纳入标准为有术前皮肤标记的照片证据,以表明乳房尺寸和所选的植入物型号。采用多变量逻辑回归来确定与选择改变相关的变量。
在研究的496名女性中,308例(62.1%)术前植入物选择在手术期间发生了改变。计划改变与涉及对侧乳房缩小成形术的对称手术(比值比[OR]=1.92;95%置信区间[CI],1.12至3.29)和对侧乳房上提术(OR=2.26;95%CI,1.29至3.96)显著相关,但与体重指数无关。70例(14.1%)所需植入物宽度变化超过0.5厘米,而215例(43.2%)高度变化超过0.5厘米。术前宽度较大(15.5厘米时OR=9.66)和术前高度较小(10.5厘米时OR=2.97)时改变的可能性较高。平均随访16.6个月时,92.1%的病例患者满意度良好或一般,5.9%的植入物已被更换为另一种型号,这表明围手术期植入物选择通常是合适的。
本研究记录了尽管术前规划准确,但由于人体测量学上相对较小的差异,植入物选择在围手术期仍被更改的频率。乳房尺寸的围手术期重新计算在患者再次手术率方面可能具有优势。宽度的变化比高度和突出度的变化更不频繁。对侧手术、宽度大和高度小是最具影响力的因素。证据级别:IV级,风险/预后研究。